Cover Image
市場調查報告書

MediPost Co., Ltd. : 產品平台分析

MediPost Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224718
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
MediPost Co., Ltd. : 產品平台分析 MediPost Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 26 Pages
簡介

Medipost Co, Ltd.是正在開發治療膝關節軟骨和神經及肺系統、造血細胞移植領域用幹細胞再生治療藥之生物科技企業。該公司同時也提供孕婦和兒童及大人的維他命和營養供給劑。

本報告提供MediPost Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

MediPost Co., Ltd.的基本資料

  • MediPost Co., Ltd.概要
  • 主要資訊
  • 企業資料

MediPost Co., Ltd.:R&D概要

  • 主要的治療範圍

MediPost Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

MediPost Co., Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 第零階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

MediPost Co., Ltd.:藥物簡介

  • Pneumostem
  • human umbilical cord blood-derived mesenchymal stem cells
  • Neurostem

MediPost Co., Ltd. :開發平台分析

  • 各給藥途徑
  • 各分子類型

MediPost Co., Ltd. :最近的開發平台趨勢

MediPost Co., Ltd. :暫停中的計劃

MediPost Co., Ltd. :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07484CDB

Summary

Global Markets Direct's, 'MediPost Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the MediPost Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of MediPost Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of MediPost Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of MediPost Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the MediPost Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate MediPost Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of MediPost Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the MediPost Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of MediPost Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of MediPost Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of MediPost Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • MediPost Co., Ltd. Snapshot
    • MediPost Co., Ltd. Overview
    • Key Information
    • Key Facts
  • MediPost Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • MediPost Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • MediPost Co., Ltd. - Pipeline Products Glance
    • MediPost Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
      • Phase 0 Products/Combination Treatment Modalities
    • MediPost Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • MediPost Co., Ltd. - Drug Profiles
    • Pneumostem
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • human umbilical cord blood-derived mesenchymal stem cells
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Neurostem
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • MediPost Co., Ltd. - Pipeline Analysis
    • MediPost Co., Ltd. - Pipeline Products by Route of Administration
    • MediPost Co., Ltd. - Pipeline Products by Molecule Type
  • MediPost Co., Ltd. - Recent Pipeline Updates
  • MediPost Co., Ltd. - Dormant Projects
  • MediPost Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • MediPost Co., Ltd., Key Information
  • MediPost Co., Ltd., Key Facts
  • MediPost Co., Ltd. - Pipeline by Indication, 2015
  • MediPost Co., Ltd. - Pipeline by Stage of Development, 2015
  • MediPost Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • MediPost Co., Ltd. - Phase II, 2015
  • MediPost Co., Ltd. - Phase I, 2015
  • MediPost Co., Ltd. - Phase 0, 2015
  • MediPost Co., Ltd. - Preclinical, 2015
  • MediPost Co., Ltd. - Pipeline by Route of Administration, 2015
  • MediPost Co., Ltd. - Pipeline by Molecule Type, 2015
  • MediPost Co., Ltd. - Recent Pipeline Updates, 2015
  • MediPost Co., Ltd. - Dormant Developmental Projects,2015

List of Figures

  • MediPost Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • MediPost Co., Ltd. - Pipeline by Stage of Development, 2015
  • MediPost Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • MediPost Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • MediPost Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top